Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Virtual Advisory Committees: US FDA Clears A Big Test With OxyContin Meeting

Sep 18 2020

• By Michael McCaughan

Big Important Day Date Reminder Circled Calendar

Related Content

Virtual Advisory Committees: Who Will Be First In Line To Test On-Line Meetings?

Apr 30 2020

COVID Vaccine Advisory Committee: Be Careful What You Wish For

Aug 13 2020

OxyContin Abuse Deterrent Formulation Voted Beneficial By FDA Panel, But Questions Remain

Sep 13 2020

OxyContin Reformulation Reduced Abuse Via Non-Oral Routes But Not Overall Abuse, US FDA Finds

Sep 09 2020

Related Companies

Purdue Pharma L.P.

Additional Topics

United States Advisory Committees Coronavirus COVID-19 FDA Regulation Drug Safety Post Market Regulation & Studies BioPharmaceutical Infectious Diseases Neurology

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.